| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.10. | EU Regulators Reject Remedies, Launch Antitrust Review of Anglo American's Nickel Sale | ||
| 29.10. | Hedge Funds Invoke Antitrust Law in Landmark Selecta Debt Battle | ||
| 29.10. | Judge Dismisses NASCAR's Antitrust Counterclaim Against 23XI and Front Row Motorsports | ||
| 28.10. | Judge Allows Celonis Antitrust Lawsuit Against SAP to Proceed | ||
| 28.10. | Cleary Gottlieb Strengthens UK Antitrust Bench With White & Case Partner Hire | ||
| 28.10. | Federal Courts Align on Google Ad Tech Monopoly Rulings | ||
| 28.10. | EU's AI Act Brings Antitrust Scrutiny to the Heart of Artificial Intelligence Governance | ||
| 28.10. | Apple Chip Suppliers Skyworks and Qorvo to Merge in $22 Billion Deal | ||
| 28.10. | Sam Altman to Receive No Stake in OpenAI's New Structure Despite Microsoft's Major Investment | ||
| 28.10. | Canada Judge Clears Key Beef Price-Fixing Case to Proceed | ||
| 28.10. | Swedish Giant Klarna Sues Google in $8.3 Billion Antitrust Battle | ||
| 28.10. | Zuckerberg Consulted Attorney General as Meta Faced Antitrust Scrutiny | ||
| 28.10. | With Congress Still MIA on AI, State Legislators Expand Their Efforts at Regulation | ||
| 28.10. | CRA Expands Antitrust & Competition Practice with New Vice President | ||
| 28.10. | PayPal Partners With OpenAI to Bring Payments Directly Into ChatGPT | ||
| 28.10. | Judge Reverses Class Action Status in Apple App Store Monopoly Case | ||
| 27.10. | Compass Demands Redfin Produce Key Files in Antitrust Battle with Zillow | ||
| 27.10. | Former FTC Trial Leader Joins WilmerHale's Antitrust Team | ||
| 27.10. | Canada to Ban Non-Compete Clauses in Federally Regulated Workplaces | ||
| 27.10. | Exxon Mobil Takes Legal Action Over California's Emissions Disclosure Laws | ||
| 27.10. | AI-Enabled Medical Tech Faces Regulatory and Patent Hurdles | ||
| 27.10. | Teva Settles Claims Alleging It Blocked Cheaper QVAR Alternatives | ||
| 27.10. | SEC Crypto Counsel Named to Head CFTC | ||
| 27.10. | Microsoft in Trouble in Australia: Watchdog Alleges AI Price Hikes | ||
| 27.10. | Novartis to Acquire Avidity Biosciences in $12 Billion Deal to Expand Neuroscience Portfolio |